| Form type | Sec Links | Description | Filing date | Reporting date |
|---|---|---|---|---|
| SC 13G/A | Report | SEC SCHEDULE 13G | Apr 10, 2024 | |
| SC 13G/A | Report | SC 13G/A | Feb 12, 2024 | |
| SC 13G/A | Report | SEC SCHEDULE 13G | Feb 9, 2024 | |
| SC 13G/A | Report | AMENDMENT NO. 4 | Feb 5, 2024 | |
| SC 13G/A | Report | SC 13G/A | Jan 29, 2024 | |
| SC 13G/A | Report | SC 13G/A | Jan 10, 2024 | |
| SC 13G/A | Report | SC 13G/A | Apr 11, 2023 | |
| SC 13G | Report | SEC SCHEDULE 13G | Feb 13, 2023 | |
| SC 13G/A | Report | SC 13G/A | Feb 10, 2023 | |
| SC 13G/A | Report | SC 13G/A | Feb 10, 2023 | |
| SC 13G/A | Report | AMENDMENT NO. 3 | Feb 3, 2023 | |
| SC 13G/A | Report | SC13G/A | Feb 14, 2022 | |
| SC 13G/A | Report | SEC SCHEDULE 13G | Feb 11, 2022 | |
| SC 13G/A | Report | SC 13G/A | Feb 9, 2022 | |
| SC 13G/A | Report | AMENDMENT NO. 2 | Feb 4, 2022 | |
| SC 13G/A | Report | SC 13G/A | Sep 10, 2021 | |
| SC 13G/A | Report | SEC SCHEDULE 13G | Aug 10, 2021 | |
| SC 13G/A | Report | SCHEDULE 13G/A | Feb 16, 2021 | |
| SC 13G/A | Report | SEC SCHEDULE 13G | Feb 16, 2021 | |
| SC 13G/A | Report | SC 13G/A | Feb 11, 2021 | |
| SC 13G/A | Report | AMENDMENT NO. 1 | Feb 5, 2021 | |
| SC 13G | Report | SC 13G | Oct 9, 2020 | |
| SC 13G | Report | SEC SCHEDULE 13G | Sep 10, 2020 | |
| SC 13G | Report | SEC SCHEDULE 13G | Sep 10, 2020 | |
| SC 13G/A | Report | SCHEDULE 13 G/A - AMENDMENT 1 | Feb 13, 2020 | |
| SC 13G | Report | SC 13G | Feb 12, 2020 | |
| SC 13G | Report | Feb 12, 2020 | ||
| SC 13G | Report | SCHEDULE 13G | Nov 26, 2019 | |
| SC 13G/A | Report | NEW ENTERPRISE ASSOCIATES 15, L.P. / CRISPR THERAPEUTICS AG - 13G/A (#2) | Feb 12, 2019 | |
| SC 13G/A | Report | NEA 15 / CRISPR THERAPEUTICS AG - 13G/A - AMEND. #1 | Feb 12, 2018 | |
| SC 13G | Report | SC 13G | Feb 13, 2017 | |
| SC 13G | Report | NEA 15 / CRISPR THERAPEUTICS AG - 13G | Feb 6, 2017 |